In the last trading session, 0.94 million shares of the Emergent Biosolutions Inc (NYSE:EBS) were traded, and its beta was 1.99. Most recently the company’s share price was $6.62, and it changed around -$0.37 or -5.29% from the last close, which brings the market valuation of the company to $359.32M. EBS currently trades at a discount to its 52-week high of $15.10, offering almost -128.1% off that amount. The share price’s 52-week low was $4.02, which indicates that the current value has risen by an impressive 39.27% since then. We note from Emergent Biosolutions Inc’s average daily trading volume that its 10-day average is 1.79 million shares, with the 3-month average coming to 1.27 million.
Emergent Biosolutions Inc stock received a consensus recommendation rating of Buy, based on a mean score of 2.33. If we narrow it down even further, the data shows that 0 out of 3 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 0 recommended EBS as a Hold, whereas 1 deemed it a Buy, and 1 rated it as Underweight.
Emergent Biosolutions Inc (NYSE:EBS) trade information
Instantly EBS has showed a red trend with a performance of -5.29% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 7.29 on recent trading dayincreased the stock’s daily price by 9.19%. The company’s shares are currently down -11.62% year-to-date, but still up 4.25% over the last five days. On the other hand, Emergent Biosolutions Inc (NYSE:EBS) is 4.58% up in the 30-day period. We can see from the shorts that 7.99 million shares have been sold at a short interest cover period of 7.18 day(s).
The consensus price target as assigned by Wall Street analysts is $51.5, which translates to bulls needing to increase their stock price by 87.15% from its current value. Analyst projections state that EBS is forecast to be at a low of $38 and a high of $65.
EBS Dividends
Emergent Biosolutions Inc’s next quarterly earnings report is expected to be released on 2025-May-07.
Emergent Biosolutions Inc (NYSE:EBS)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 2.83% of Emergent Biosolutions Inc shares, and 67.20% of them are in the hands of institutional investors. The stock currently has a share float of 69.16%. Emergent Biosolutions Inc stock is held by 197.0 institutions, with BLACKROCK INC. being the largest institutional investor. By 2024-06-30, it held 7.2992% of the shares, which is about 3.84 million shares worth $26.18 million.
VANGUARD GROUP INC, with 6.97% or 3.67 million shares worth $25.0 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
American Century ETF Trust-Avantis U.S. Small Cap Value ETF and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund were the top two Mutual Funds as of May 31, 2025 . The former held 1.94 shares worth $12.87 million, making up 3.58% of all outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund held roughly 1.57 shares worth around $10.41 million, which represents about 2.90% of the total shares outstanding.
